K3R-29177-39715 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-08
Dose 1 — Pfizer-BioNTech
2022-07-29
Dose 2 — Pfizer-BioNTech
2022-09-29
Dose 3 — Pfizer-BioNTech
2023-01-24
Registered in v-safe
2023-03-30
Survey response — 6 months, dose 3, under 3
MedDRA: Ear disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-30
Report sent to call center — 6 months, dose 3, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-31
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-08	Pfizer-BioNTech	No
2	2022-07-29	Pfizer-BioNTech	No
3	2022-09-29	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ear disorder	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release